Atlas Trials

Trametinib With GSK2141795 in BRAF Wild-type Melanoma

Clinical trial NCT01941927 · COMPLETED

Trial details

NCT number
NCT01941927
Sponsor
Adil Daud
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Melanoma
Start date
2013-09-10
Primary completion
2014-10-14
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.